Tolerability of enalapril initiation by patients with left ventricular dysfunction: Results of the medication challenge phase of the studies of left ventricular dysfunction
Open Access
- 31 August 1994
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 128 (2), 358-364
- https://doi.org/10.1016/0002-8703(94)90490-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.Circulation, 1983
- Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.Heart, 1983
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981
- Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failureAmerican Heart Journal, 1981
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978